Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan

期刊论文
发表日期：

2024年9月12日

查看全文

Dan Tomomasa,
Tasuku Suzuki,
Ichiro Takeuchi,
Kimitoshi Goto,
Shin-Ichiro Hagiwara,
Dai Keino,
Satoshi Saida,
Takashi Ishige,
Takahiro Kudo,
Katsuhide Eguchi,
Masataka Ishimura,
Yusuke Matsuda,
Taizo Wada,
Yoshiya Ito,
Motohiro Kato,
Yoji Sasahara,
Tomohiro Morio,
Katsuhiro Arai,
Holm H Uhlig,
Hirokazu Kanegane

摘要

Background

IL10RA (IL10 receptor subunit alpha) deficiency is an autosomal recessive disease that causes inflammatory bowel disease during early infancy. Its clinical course is often fatal and the only curative treatment is allogeneic hematopoietic cell transplantation (HCT). In Japan, only case reports are available, and there are no comprehensive reports of treatment outcomes.

Methods

We retrospectively analyzed patients with IL10RA deficiency in Japan.

Results

Two newly identified and five previously reported patients were included in this study. Five patients underwent HCT; one untransplanted patient survived to age 14, and one died of influenza encephalopathy before transplantation. All five HCT recipients underwent HCT at the age before 2 years. They all were conditioned with fludarabine/busulfan- or fludarabine /melphalan-based regimens. The donor source was human leukocyte antigen haploidentical donor bone marrow (BM) for two patients and unrelated umbilical cord blood (CB) for two patients. One patient experienced graft failure with unrelated CB and required a second transplant with unrelated BM. All patients who underwent HCT survived and demonstrated an improved performance status.

Conclusion

In cases of IL10RA deficiency, the need for transplantation should be promptly assessed, and early transplantation should be considered. (190/250)